Condition
Radioisotopes
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07362485Not ApplicableRecruiting
Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)
NCT07146295Not ApplicableRecruiting
Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer
NCT02975739Not ApplicableTerminatedPrimary
Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors
NCT00586950Completed
123I-BMIPP SPECT Analysis for Decreasing Cardiac Events in Hemodialysis Patients
Showing all 4 trials